This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

ROBERT H. PRESTON, M.D.; LEON GOLDMAN, M.D.

AMA Arch Derm Syphilol. 1952;66(3):391-392.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Intravenous drip therapy with corticotropin has become increasingly popular in all fields of medicine since the work of Gordon¹ and Renold,² who showed the sustained value of this type of therapy. Its application to dermatology has been reported.³ It is important to emphasize that there are in general three different types of daily intravenous drips: (1) the continuous (24 hours), (2) the intermittent (7 or 8 hours), and (3) the combined (Hampton), in which 10 mg. of corticotropin in 1,000 cc. of solution is given intravenously for 12 hours, then 10 mg. of corticotropin is administered intramuscularly.⁴

Advantages in the intravenous use of corticotropin are as follows:

1. The material and equipment needed to obtain results equal to, or better than, those with standard intramuscular uses are low in cost.
   
2. In some cases the intravenous drip therapy will stimulate the adrenal cortex when intramuscular
   

Author Affiliations
CINCINNATI

From the Department of Dermatology and Syphilology, University of Cincinnati College of Medicine.

Footnotes
The corticotropin used in this study was furnished by R. C. Lemon, Pacific Laboratories, Inc., Richmond, Calif.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?